Vimarsana
Biggest News Aggregation in the World

Page 2 - John Mendlein News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from John Mendlein. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In John Mendlein Today - Breaking & Trending Today

CRISPR Continuous to Innovate! Exploring the Future of Cell & Gene Therapy, Industry Leaders Converge at the 2024 GenScript Biotech Global Forum - Vimarsana News

CRISPR Continuous to Innovate! Exploring the Future of Cell & Gene Therapy, Industry Leaders Converge at the 2024 GenScript Biotech Global Forum

NANJING, China, Dec. 7, 2023 /PRNewswire/ -- The rapid advancement of technology has propelled the field of life sciences into unprecedented growth, constantly expanding our understanding and imagination. Particularly in the field of cellular gene therapy, a series of recent positive developments have been overwhelming. Recently, the world's first CRISPR/Cas9 gene editing therapy received market approval in the UK....

Laronde, Senda Biosciences merge to create new Flagship company - Vimarsana News

Laronde, Senda Biosciences merge to create new Flagship company

BioPharma

Why rings of RNA could be the next blockbuster drug - Vimarsana News

Why rings of RNA could be the next blockbuster drug

The commercial success of RNA vaccines for COVID-19 has revved up interest in circular RNAs as the next generation of therapies. The commercial success of RNA vaccines for COVID-19 has revved up interest in circular RNAs as the next generation of therapies.

Source: nature.com
One Fate Therapeutics Insider Raised Stake By 83% In Previous Year - Vimarsana News

One Fate Therapeutics Insider Raised Stake By 83% In Previous Year

Viewing insider transactions for Fate Therapeutics, Inc.'s ( NASDAQ:FATE ) over the last year, we see that insiders...

Source: yahoo.com
Former Rubius, Laronde CEO Cagnoni to join Incyte - Vimarsana News

Former Rubius, Laronde CEO Cagnoni to join Incyte

BioPharma